BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 18601598)

  • 21. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population.
    Vasilopoulos Y; Sarafidou T; Bagiatis V; Skriapa L; Goutzelas Y; Pervanidou P; Lazopoulou N; Chrousos GP; Mamuris Z
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):613-7. PubMed ID: 21473680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins.
    Ken-Dror G; Goldbourt U; Dankner R
    J Hum Genet; 2010 May; 55(5):300-7. PubMed ID: 20395964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
    Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
    Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
    Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
    Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction.
    De Caterina R; Talmud PJ; Merlini PA; Foco L; Pastorino R; Altshuler D; Mauri F; Peyvandi F; Lina D; Kathiresan S; Bernardinelli L; Ardissino D;
    Atherosclerosis; 2011 Feb; 214(2):397-403. PubMed ID: 21130994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.
    Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM
    Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
    Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
    Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.
    Sóter MO; Gomes KB; Fernandes AP; Carvalho Md; Pinheiro PS; Bosco AA; Silva DD; Sousa MO
    Mol Biol Rep; 2012 Jul; 39(7):7541-8. PubMed ID: 22350263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome.
    Niculescu LS; Fruchart-Najib J; Fruchart JC; Sima A
    Clin Chem Lab Med; 2007; 45(9):1133-9. PubMed ID: 17635078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults.
    Coban N; Onat A; Guclu-Geyik F; Komurcu-Bayrak E; Can G; Erginel-Unaltuna N
    Clin Chim Acta; 2014 Apr; 431():244-9. PubMed ID: 24508624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
    Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
    Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
    Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension].
    Liu A; Li L; Cao W; Shan S; Lu J; Guo X; Hu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):151-7. PubMed ID: 15793775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study.
    Cardona F; Guardiola M; Queipo-Ortuño MI; Murri M; Ribalta J; Tinahones FJ
    Atherosclerosis; 2009 Sep; 206(1):148-52. PubMed ID: 19344899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.
    Hong CJ; Chen TT; Bai YM; Liou YJ; Tsai SJ
    World J Biol Psychiatry; 2012 Jan; 13(1):22-9. PubMed ID: 21375366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of the APOA5/A4/C3/A1 gene cluster and APOB gene polymorphisms with dyslipidemia.
    Ou HJ; Huang G; Liu W; Ma XL; Wei Y; Zhou T; Pan ZM
    Genet Mol Res; 2015 Aug; 14(3):9277-90. PubMed ID: 26345861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.